Back
Reshape Lifesciences 10K Form
Sell
28
RSLS
Reshape Lifesciences
Last Price:
5.38
Seasonality Move:
38.21%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RSLS News And Ratings
See the #1 stock for the next 7 days that we like better than RSLS
RSLS Financial Statistics
Sales & Book Value
Annual Sales: | $8.68M |
---|---|
Cash Flow: | $-1.36M |
Price / Cash Flow: | 0 |
Annual Sales: | $5.99 |
Price / Book: | 0.95 |
Profitability
EPS (TTM): | -72.05850 |
---|---|
Net Income (TTM): | $-9.02M |
Gross Margin: | $5.55M |
Return on Equity: | -187.5% |
Return on Assets: | -100.3% |
Reshape Lifesciences Earnings Forecast
Key Reshape Lifesciences Financial Ratios
- The Gross Profit Margin over the past 16 years for RSLS is 63.93%.
- The Selling, General & Administrative Expenses for RSLS have been equal to 205.95% of Gross Profit Margin.
- The Research & Development expenses have been 26.68% of Revenue.
- The Interest Expense is -0.24% of Operating Income.
- The Net Earning history of RSLS is -131.22% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 11 years.
Reshape Lifesciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | RSLS |
CUSIP: | 761123 |
Website: | reshapelifesciences.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.9 |
Quick Ratio: | 0.77 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
RSLS Technical Analysis vs Fundamental Analysis
Sell
28
Reshape Lifesciences (RSLS)
is a Sell
Is Reshape Lifesciences a Buy or a Sell?
-
Reshape Lifesciences stock is rated a Sell
The current Reshape Lifesciences [RSLS] share price is $5.66. The Score for RSLS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.